AGP Executive Report
Last update: 5 hours agoSynthetic Food Safety: A peer-reviewed study warns synbio “animal-free” milk may contain dozens of uncharacterized compounds and fungal proteins never tested for human consumption, raising fresh questions about regulation and consumer safety. Oncology Updates: BeOne Medicines shared new EHA 2026 data on tacabrutideg (BTK degrader) in CLL/SLL and continued results for zanubrutinib plus sonrotoclax across B-cell cancers. Medication Access & Waste: Tanner Health and InStockRx are partnering to reduce “structural gap” medication waste by moving surplus doses to patients needing them. Drug Delivery Reality Check: Research suggests some medications with protective coatings can dissolve early depending on the drink’s chemistry, not just the pill itself. Antibiotic-Resistant Threats: LyticGen filed a provisional patent for a CRISPR-enhanced bacteriophage approach targeting MRSA with its VDX-10 program. Fraud & Accountability: A Georgia lab owner was sentenced after pleading guilty to a $330,000 Medicaid fraud scheme involving false genetic testing claims. Behavioral Health Capacity: Oregon announced a major expansion of mental health and addiction residential treatment beds, adding more than 1,000 beds already open. Policy & Tech Oversight: CMS created a new Office of Health Technology and Products and issued Medicaid demonstration budget-neutrality guidance. Public Health & Disruption: Firefighters battled a massive Tracy, California medical supply warehouse blaze, with reports that sprinklers and hydrants failed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.